AI assistant
Sending…
VERU INC. — Director's Dealing 2013
May 10, 2013
34598_dirs_2013-05-10_d4101a2f-e1ab-414a-ac30-9685dcbf6cff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FEMALE HEALTH CO (FHCO)
CIK: 0000863894
Period of Report: 2013-05-08
Reporting Person: BETHUNE DAVID R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-08 | Common Stock, par value $.01 per share | M | 6250 | $3.92 | Acquired | 183665 | Direct |
| 2013-05-08 | Common Stock, par value $.01 per share | F | 3032 | $8.08 | Disposed | 180633 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-08 | Common Stock Option | $3.92 | M | 6250 | Disposed | 2019-06-29 | Common Stock (6250) | Direct |
Footnotes
F1: Pursuant to a cashless option exercise program, the reporting person surrendered to The Female Health Company ("FHCO") the requisite number of shares subject to the option to pay the exercise price based on the market price of FHCO common stock on the trading day immediately preceding the date of exercise which was $8.08 per share.
F2: Options for one thirty-sixth of the shares vest on the 29th of each month for the 36-month period commencing on June 29, 2009 and ending on May 29, 2012.
More from VERU INC.
Capital/Financing Update
2026
Jul 2
Capital/Financing Update
2026
Jul 2
Regulatory Filings
2026
Jun 4
Share Issue/Capital Change
2026
May 13
Interim / Quarterly Report
2026
May 13
Call Transcript
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 16
Capital/Financing Update
2026
Apr 7